Arsenal’s Lucas Torreira FINALLY set for Premier League exit as he agrees personal terms with Galatasaray and will undergo his medical after the clubs sanction £5.5million sale
- Arsenal’s Lucas Torreira will join Galatasaray in a move worth £5.5million
- The Arsenal midfielder agreed personal terms with his new club on Friday
- He will now undergo his medical and become the club’s eighth summer signing
Arsenal’s Lucas Torreira has reached an agreement on personal terms to join Turkish giants Galatasaray.
The two clubs had already negotiated a £5.5million fee with Torreira settling personal details with his soon-to-be new club in a meeting in Italy on Friday.
He will now undergo a medical before being unveiled as a Galatasaray player in the coming days.
Arsenal’s Lucas Torreira will join Galatasaray after agreeing personal terms with the club
Torreira helped Arsenal lift the FA Cup during Mikel Arteta’s first season in charge at the club
The defensive midfielder was brought to Arsenal in 2019 by former Gunners boss Unai Emery but was shunted out by current manager Mike Arteta.
Torreira has spent the last two seasons of his Arsenal career on loan at Atletico Madrid and Fiorentina and was unwanted by Arteta when he returned for pre-season training.
Arteta has sanctioned Torreira’s move as he views the defensive midfielder as a sellable asset
Arsenal have been one of the transfer markets biggest movers and have wanted to secure an exit for Torreira as the club look to lower their current wage bill.
Torreira has made 89 appearances for Arsenal across all competitions and helped the club lift the FA Cup during Arteta’s first season in the dugout at the Emirates.
He will join a Galatasaray side that massively underachieved last season, finishing 13th in the Turkish Super Lig and 29 points behind champions Trabzonspor as they missed out on Champions League football.
The Uruguayan will become Galatasaray’s eight summer signing as the club seek to bounce back following a torrid previous campaign.
Share this article
Source: Read Full Article